Jim - medXcentral's Page

Indianapolis getting money for health centers - Palladium-Item

Indianapolis getting money for health centers Palladium-Item Community health centers serve the uninsured and underinsured. About $2 billion in stimulus funds are dedicated to local health centers, and about half that ...

Family HealthCare Center gets $6.6M grant for new facility - In-Forum

Family HealthCare Center gets $6.6M grant for new facility In-Forum FARGO – Family HealthCare Center in Fargo has been awarded a $6.6 million federal stimulus grant that will allow it to move ahead with plans to buy and ... President is eyeing new stimulus in the area of $150 billion

States expanding coverage despite recession - FierceHealthcare

States expanding coverage despite recession FierceHealthcare ... obtain health coverage, according to a new report from the Kaiser Family Foundation. These expansions were financed largely by federal stimulus dollars, ...

GlycoMimetics, Inc.: Series C $38M

GlycoMimetics (Gaithersburg, MD) a clinical-stage small molecule glycobiology company focused on cancer, inflammation and infectious disease, closed a $38M Series C financing. Participants include Genzyme Ventures, New Enterprise Associates, Novartis Venture Fund, Anthem Capital Management and Alliance Technology Ventures. A more detailed company profile recently appeared on Life Science Deal Flow [HERE].

Metabolon, Inc.: Series C $6M

Metabolon (Durham, NC) a metabolomics services and informatics company focused on detection of small molecule biomarkers, closed a $6M Series C financing, bringing the entire financing round to $12.3M. Participants include Syngenta Ventures, Fletcher Spaght Ventures, Sevin Rosen Funds, Aurora Funds, Harris and Harris Group, Fulcrum Financial Partners and Alexandria Equities.

Evolva, SA: Series B $27.5M

Evolva (Switzerland) a clinical-stage synthetic biology small molecule company focused on proteinuri kidney and cardiovascular disease, closed a $27,5M Series B financing. Participants include Wellington Partners Venture Capital, Aravis Venture Associates, Auriga Partners and Vinci Capital.

Direct Flow Medical, Inc.: Series C $40M

Direct Flow Medical (Santa Rosa, CA) a development-stage medical device company focused on a percutaneous aortic tissue valve prosthesis, closed a $40M Series C financing. Participants include Johnson & Johnson Development Corp., Foundation Medical Partners, VantagePoint Venture Partners, ePlanet Ventures, EDF Ventures, New Leaf Venture Partners and Spray Venture Partners.

Molecular Detection, Inc.: Series C $3.3M

Molecular Detection (Wayne, PA) a development-stage molecular diagnostics company focused on reat-time PCR of MRSA detection, closed a $3.3M Series C financing. Participants include MentorTech Ventures, Ben Franklin Technology Partners, Robin Hood Ventures and the Mid-Atlantic Angel Group.